Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

STOK holding history

Stoke Therapeutics, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

STOK overviewAll 13F holders of STOKFull Q2 2026 holdings

Shares (Q2 2026)
207,112
Value
$6.78M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of STOK by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026207,112$6.78M<0.1%+48,808+30.8%AddedHolders
Q1 2026158,304$5.15M<0.1%−11,409−6.7%ReducedHolders
Q4 2025169,713$5.39M<0.1%−136,324−44.5%ReducedHolders
Q3 2025306,037$7.19M<0.1%−46,678−13.2%ReducedHolders
Q2 2025352,715$4.00M<0.1%+180,884+105.3%AddedHolders
Q1 2025171,831$1.14M<0.1%−6,013−3.4%ReducedHolders
Q4 2024177,844$1.96M<0.1%+99,532+127.1%AddedHolders
Q3 202478,312$962.5K<0.1%−39,942−33.8%ReducedHolders
Q2 2024118,254$1.60M<0.1%+78,839+200.0%AddedHolders
Q1 202439,415$532.1K<0.1%+9,642+32.4%AddedHolders
Q4 202329,773$156.6K<0.1%+9,498+46.8%AddedHolders
Q3 202320,275$79.9K<0.1%−2,806−12.2%ReducedHolders
Q2 202323,081$245.4K<0.1%+9,004+64.0%AddedHolders
Q1 202314,077$117.3K<0.1%−661−4.5%ReducedHolders
Q4 202214,738$136.0K<0.1%+11,046+299.2%AddedHolders
Q3 20223,692$47.0K<0.1%+3,692NewHolders
Q2 20220$00.0%−51,941−100.0%Sold outHolders
Q1 202251,941$1.09M<0.1%+8,664+20.0%AddedHolders
Q4 202143,277$1.04M<0.1%+10,464+31.9%AddedHolders
Q3 202132,813$835.0K<0.1%+28,571+673.5%AddedHolders
Q2 20214,242$143.0K<0.1%−11,073−72.3%ReducedHolders
Q1 202115,315$595.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.